195
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Scaffold identification and drug repurposing for finding potential Dengue envelope inhibitors through ligand-based pharmacophore model

, & ORCID Icon
Pages 11916-11929 | Received 15 Oct 2022, Accepted 24 Dec 2022, Published online: 29 Jan 2023

References

  • Abdulrahman, H. S., et al. (2020). Synthesis of phthalimide imine derivatives as a potential anticancer agent. Journal of Chemistry, 2020.
  • Anasir, M. I., Ramanathan, B., & Poh, C. L. (2020). Structure-based design of antivirals against envelope glycoprotein of dengue virus. Viruses, 12(4), 367.
  • Aoki, C., Hidari, K. I. P. J., Itonori, S., Yamada, A., Takahashi, N., Kasama, T., Hasebe, F., Islam, M. A., Hatano, K., Matsuoka, K., Taki, T., Guo, C.-T., Takahashi, T., Sakano, Y., Suzuki, T., Miyamoto, D., Sugita, M., Terunuma, D., Morita, K., & Suzuki, Y. (2006). Identification and characterization of carbohydrate molecules in mammalian cells recognized by dengue virus type 2. Journal of Biochemistry, 139(3), 607–614.
  • Bowers, K. J., et al. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters, Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, 84–es.
  • Bressanelli, S., Stiasny, K., Allison, S. L., Stura, E. A., Duquerroy, S., Lescar, J., Heinz, F. X., & Rey, F. A. (2004). Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation. The EMBO Journal, 23(4), 728–738.
  • Chakraborty, S., et al. (2020). Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients-a phase II randomized controlled clinical trial. EClinicalMedicine, 29, 100624.
  • Chen, Y.-C., Wang, S.-Y., & King, C.-C. (1999). Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. Journal of Virology, 73(4), 2650–2657.
  • Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J., & Marks, R. M. (1997). Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Medicine, 3(8), 866–871.
  • Cheng, G. (2012). Eltrombopag, a thrombopoietin-receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile. Therapeutic Advances in Hematology, 3(3), 155–164.
  • Deeks, E. D. (2015). Safinamide: First global approval. Drugs, 75(6), 705–711. https://doi.org/10.1007/s40265-015-0389-7
  • Du, Q.-H., Peng, C., & Zhang, H. (2013). Polydatin: A review of pharmacology and pharmacokinetics. Pharmaceutical Biology, 51(11), 1347–1354.
  • Guzman, M. G., et al. (2016). Dengue infection. Nature Reviews Disease Primers, 2(1), 1–25.
  • Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296.
  • Hidari, K., & Suzuki, T. (2011). Dengue virus receptor. Tropical Medicine and Health, 39(4 Suppl), 37–43.
  • Huang, N., Shoichet, B. K., & Irwin, J. J. (2006). Benchmarking sets for molecular docking. Journal of Medicinal Chemistry, 49(23), 6789–6801.
  • Truchon, J.-F., & Bayly, C. I. (2007). Evaluating virtual screening methods: Good and bad metrics for the "early recognition" problem. Journal of Chemical Information and Modeling, 47(2), 488–508.
  • Florkowski, C. (2008). Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: Communicating the performance of diagnostic tests. The Clinical Biochemist, 29(Suppl 1), S83–S87.
  • Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012). Zinc: A free tool to discover chemistry for biology. Journal of Chemical Information and Modeling, 52(7), 1757–1768. https://doi.org/10.1021/ci3001277
  • Jain, S. K., & Seema. (2005). Molecular mechanism of pathogenesis of dengue virus: Entry and fusion with target cell. Indian journal of Clinical Biochemistry: IJCB, 20(2), 92–103.
  • Jindadamrongwech, S., Thepparit, C., & Smith, D. R. (2004). Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Archives of Virology, 149(5), 915–927.
  • Klein, D. E., Choi, J. L., & Harrison, S. C. (2013). Structure of a dengue virus envelope protein late-stage fusion intermediate. Journal of Virology, 87(4), 2287–2293.
  • Kuter, D. J. (2016). What is the role of novel thrombopoietic agents in the management of acute leukemia? Best Practice & Research. Clinical Haematology, 29(4), 372–378. https://doi.org/10.1016/j.beha.2016.10.013
  • Lim, S. P. (2019). Dengue drug discovery: Progress, challenges and outlook. Antiviral Research, 163, 156–178.
  • Clyde, K., Kyle, J. L., & Harris, E. (2006). Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. Journal of Virology, 80(23), 11418–11431.
  • Rodenhuis-Zybert, I. A., Wilschut, J., & Smit, J. M. (2010). Dengue virus life cycle: Viral and host factors modulating infectivity. Cellular and Molecular Life Sciences: CMLS, 67(16), 2773–2786. https://doi.org/10.1007/s00018-010-0357-z
  • Limkittikul, K., Brett, J., & L'Azou, M. (2014). Epidemiological trends of dengue disease in Thailand (2000–2011): A systematic literature review. PLoS Neglected Tropical Diseases, 8(11), e3241.
  • Luengo, J. I. (2004). Discovery of SB-497115, a small-molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia. American Society of Hematology.
  • De Maria, S. (2013). Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell. Journal of Translational Medicine, 11(1), 1–11.
  • Martı́nez-Barragán, J., de, J., & del Angel, R. M. (2001). Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection. Journal of Virology, 75(17), 7818–7827.
  • McIntyre, P. B., Rodrigues, C. A., Lennard-Jones, J. E., Barrison, I. G., Walker, J. G., Baron, J. H., & Thornton, P. C. (1988). Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double‐blind comparison with sulphasalazine. Alimentary Pharmacology & Therapeutics, 2(3), 237–243. https://doi.org/10.1111/j.1365-2036.1988.tb00693.x
  • Melo, M. N., Sousa, F. J. R., Carneiro, F. A., Castanho, M. A. R. B., Valente, A. P., Almeida, F. C. L., Da Poian, A. T., & Mohana-Borges, R. (2009). Interaction of the Dengue virus fusion peptide with membranes assessed by NMR: The essential role of the envelope protein Trp101 for membrane fusion. Journal of Molecular Biology, 392(3), 736–746.
  • Miller, J. L., de Wet, B. J. M., Martinez-Pomares, L., Radcliffe, C. M., Dwek, R. A., Rudd, P. M., & Gordon, S. (2008). The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathogens, 4(2), e17.
  • Modis, Y. (2003). A ligand-binding pocket in the dengue virus envelope glycoprotein. Proceedings of the National Academy of Sciences, 100(12), 6986–6991.
  • Monk, J. P., & Todd, P. A. (1987). Bezafibrate. Drugs, 33(6), 539–576. https://doi.org/10.2165/00003495-198733060-00002
  • Navarro-Sanchez, E., Altmeyer, R., Amara, A., Schwartz, O., Fieschi, F., Virelizier, J.-L., Arenzana-Seisdedos, F., & Desprès, P. (2003). Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Reports, 4(7), 723–728.
  • Nieminen, M. S., Fruhwald, S., Heunks, L. M. A., Suominen, P. K., Gordon, A. C., Kivikko, M., & Pollesello, P. (2013). Levosimendan: Current data, clinical use and future development. Heart, Lung and Vessels, 5(4), 227–245.
  • Nonyong, P., Ekalaksananan, T., Phanthanawiboon, S., Aromseree, S., Phadungsombat, J., Nakayama, E. E., Shioda, T., Sawaswong, V., Payungporn, S., Thaewnongiew, K., Overgaard, H. J., Bangs, M. J., Alexander, N., & Pientong, C. (2021). Dengue virus in humans and mosquitoes and their molecular characteristics in northeastern Thailand 2016–2018. PloS One, 16(9), e0257460.
  • Olnes, M. J., Scheinberg, P., Calvo, K. R., Desmond, R., Tang, Y., Dumitriu, B., Parikh, A. R., Soto, S., Biancotto, A., Feng, X., Lozier, J., Wu, C. O., Young, N. S., & Dunbar, C. E. (2012). Eltrombopag and improved hematopoiesis in refractory aplastic anemia. The New England Journal of Medicine, 367(1), 11–19.
  • Poh, M. K., Yip, A., Zhang, S., Priestle, J. P., Ma, N. L., Smit, J. M., Wilschut, J., Shi, P.-Y., Wenk, M. R., & Schul, W. (2009). A small molecule fusion inhibitor of dengue virus. Antiviral Research, 84(3), 260–266.
  • Roos, K., Wu, C., Damm, W., Reboul, M., Stevenson, J. M., Lu, C., Dahlgren, M. K., Mondal, S., Chen, W., Wang, L., Abel, R., Friesner, R. A., & Harder, E. D. (2019). OPLS3e: Extending force field coverage for drug-like small molecules. Journal of Chemical Theory and Computation, 15(3), 1863–1874.
  • Roy, S. (2019). Thrombopoietin receptor agonists: Can these be the future answer to the deadly thrombocytopenia in dengue fever?. Cureus, 11(4).
  • Siddique, N. (2021). Prevention and treatment of thrombocytopenia in dengue patients: A narrative review. Journal of the Faculty of Pharmacy of Istanbul University, 51(3), 411–419.
  • Singh, R., & Emmady, P. D. (2022). Rivaroxaban. In StatPearls [Internet]. StatPearls Publishing.
  • Syed, Y. Y. (2017). Ribociclib: First global approval. Drugs, 77(7), 799–807.
  • Tio, P. H., Jong, W. W., & Cardosa, M. J. (2005). Two dimensional VOPBA reveals laminin receptor (LAMR1) interaction with dengue virus serotypes 1, 2 and 3. Virology journal, 2(1), 1–11.
  • Tursi, A. (2009). Balsalazide in treating colonic diseases. Expert Opinion on Drug Metabolism & Toxicology, 5(12), 1555–1563. https://doi.org/10.1517/17425250903228842
  • Vora, A. (2010). Terizidone. The Journal of the Association of Physicians of India, 58, 267–268.
  • Wang, Q.-Y., Patel, S. J., Vangrevelinghe, E., Xu, H. Y., Rao, R., Jaber, D., Schul, W., Gu, F., Heudi, O., Ma, N. L., Poh, M. K., Phong, W. Y., Keller, T. H., Jacoby, E., & Vasudevan, S. G. (2009). A small-molecule dengue virus entry inhibitor. Antimicrobial Agents and Chemotherapy, 53(5), 1823–1831.
  • Wendling, F. (1999). Thrombopoietin: Its role from early hematopoiesis to platelet production. Haematologica, 84(2), 158–166.
  • Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z. Assempour, N., & Wilson, M. (2018). DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic acids research, 46(D1), D1074-D1082.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.